PGR
39
2
JWN
50
4
INTU
45
-4
KMB
30
2
VRTX
39
-8
CHD
32
6
DFS
68
8
PH
57
4
MMC
39
3
UPS
56
3
ADM
33
2
AVB
52
5
EMC
27
-9
MTB
44
3
CNP
54
8
UA
45
7
IFF
51
4
WDC
37
-3
AIZ
49
7
ADT
27
-11
PGR
39
2
JWN
50
4
INTU
45
-4
KMB
30
2
VRTX
39
-8
CHD
32
6
DFS
68
8
PH
57
4
MMC
39
3
UPS
56
3
ADM
33
2
AVB
52
5
EMC
27
-9
MTB
44
3
CNP
54
8
UA
45
7
IFF
51
4
WDC
37
-3
AIZ
49
7
ADT
27
-11
Financhill
Back

Triumph Financial Vs. Denali Therapeutics Industry Stock Comparison

Sell
24

TFIN
Triumph Financial

Last Price:
$87.23
Seasonality Move:
2.72%
Sell
20

DNLI
Denali Therapeutics

Last Price:
$18.74
Seasonality Move:
-5.23%
Sell
24
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $85.00. The Score for TFIN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $19.59. The Score for DNLI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $19.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.41 Sell
Relative Strength Index (14 RSI): 32.05 Sell
Chaikin Money Flow: 105930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.62 - 99.58) Sell
Bollinger Bands (100): (79.7 - 98.72) Sell

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.17 Sell
Relative Strength Index (14 RSI): 36.96 Sell
Chaikin Money Flow: 739587 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.2 - 23.5) Sell
Bollinger Bands (100): (22.63 - 28.75) Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.41 Sell
20-day SMA: 91.42 Sell
50-day SMA: 96.65 Sell
200-day SMA: 83.79 Buy
8-day EMA: 87.2 Sell
20-day EMA: 90.94 Sell
50-day EMA: 92.92 Sell
200-day EMA: 85.38 Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.43 Sell
20-day SMA: 21.23 Sell
50-day SMA: 24.21 Sell
200-day SMA: 23.06 Sell
8-day EMA: 20.33 Sell
20-day EMA: 21.33 Sell
50-day EMA: 23.24 Sell
200-day EMA: 23.67 Sell

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.22 per share.

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.79 per share.

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):